Zymeworks buying opportunity ?
Following the major setback in 2021, Zymeworks has been actively working toward FDA approval for their drug, which they’ve now successfully secured. This approval could signal the continuation of an upward trend. I’m considering a buying opportunity around the $9 range. It’s also worth noting that they were listed on NASDAQ earlier this year. Let me know your thoughts!
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.